Investigational Drug Information for Neflamapimod
✉ Email this page to a colleague
What is the development status for investigational drug Neflamapimod?
Neflamapimod is an investigational drug.
There have been 5 clinical trials for Neflamapimod.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 29th 2017.
The most common disease conditions in clinical trials are Lewy Body Disease, Dementia, and Alzheimer Disease. The leading clinical trial sponsors are EIP Pharma Inc, EIP Pharma, LLC, and Worldwide Clinical Trials.
There are sixteen US patents protecting this investigational drug and two hundred and eighty international patents.
Summary for Neflamapimod
| US Patents | 16 |
| International Patents | 280 |
| US Patent Applications | 202 |
| WIPO Patent Applications | 65 |
| Japanese Patent Applications | 15 |
| Clinical Trial Progress | Phase 2 (2017-12-29) |
| Vendors | 115 |
Recent Clinical Trials for Neflamapimod
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies | National Institute on Aging (NIA) | Phase 2 |
| Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies | Worldwide Clinical Trials | Phase 2 |
| Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies | EIP Pharma Inc | Phase 2 |
Clinical Trial Summary for Neflamapimod
Top disease conditions for Neflamapimod
Top clinical trial sponsors for Neflamapimod
US Patents for Neflamapimod
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| neflamapimod | ⤷ Try a Trial | Method of modulating stress-activated protein kinase system | INTERMUNE, INC. (Brisbane, CA) | ⤷ Try a Trial |
| neflamapimod | ⤷ Try a Trial | Formylated N-heterocyclic derivatives as FGFR4 inhibitors | NOVARTIS AG (Basel, CH) | ⤷ Try a Trial |
| neflamapimod | ⤷ Try a Trial | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD | Fulcrum Therapeutics, Inc. (Cambridge, MA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Neflamapimod
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| neflamapimod | Australia | AU2006244072 | 2025-05-10 | ⤷ Try a Trial |
| neflamapimod | Brazil | BRPI0608907 | 2025-05-10 | ⤷ Try a Trial |
| neflamapimod | Canada | CA2608116 | 2025-05-10 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
